Valanx Biotech

Develops tools for protein conjugation

placeGraz, Styria, Austria calendar_todayFounded 2017 groups11 employees language valanx.bio

Social engagement

Social engagement: 3.4K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include SOSV, xista, tecnet equity.

Investor typeCountShare
Venture capital450%
Accelerator & incubator113%
Other / undisclosed338%

Recent activity

16 Jun 2026
Event
BIO International Convention
20 May 2026
Event
Antibody Engineering & Therapeutics Europe conference
16 Apr 2026
Event
Biotech Days Panel - Engineering Success: How Partnerships Transform Early Biotech into Fundable Ventures
Coming soon